Evaluation of the analytical performance and specificity of a SARS-CoV-2 transcription-mediated amplification assay
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 294, 114182
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesThe Lancet Infectious Diseases, 2020
- High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2Journal of Clinical Virology, 2020
- Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and mythsJournal of Microbiology, Immunology and Infection, 2020
- Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing FacilityNew England Journal of Medicine, 2020
- Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmissioneLife, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- Comparison of Six Sample-to-Answer Influenza A/B and Respiratory Syncytial Virus Nucleic Acid Amplification Assays Using Respiratory Specimens from ChildrenJournal of Clinical Microbiology, 2018
- Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology2018